Abstract: The present invention provides liposomal formulations comprising a lipid vesicle and at least one single chain lipid active agent. In addition, the present invention provides methods for using the same for preventing an infection in a mammal.
Type:
Application
Filed:
March 12, 2004
Publication date:
May 5, 2005
Applicants:
OPTIME Therapeutics, Inc., Megee-Womens Health Corporation